JOINTRON

Diacerein IP 50mg+ Glucosamine Sulphate, Potassium chloride USP 750mg+ Methyl Sulfonyl Methane USP 250mg

Overview:

Jointron provides a synergistic approach to osteoarthritis management. Diacerein has been shown to slow cartilage degradation, while Glucosamine supports cartilage repair. MSM offers an additional anti-inflammatory effect. Clinical trials indicate a 25% reduction in joint stiffness after 8 weeks (Arthritis Research & Therapy, 2020).


  • Class
  • Dosage
  • Indications
  • Mechanism of action

Disease-Modifying Osteoarthritis Drug (DMOAD) + Joint Supplement

One tablet twice daily or as prescribed by the doctor

Jointron Tablets can be used in the treatment of the following conditions:

Osteoarthritis (OA)
Degenerative joint disease
Cartilage wear and tear
Chronic joint pain and stiffness
Inflammatory joint disorders
Adjunct therapy for rheumatoid arthritis (RA)
Post-traumatic joint dysfunction
Synovial fluid depletion

Diacerein inhibits IL-1β and downregulates COX-2 expression, slowing cartilage degradation and inflammation. Glucosamine promotes cartilage repair by increasing proteoglycan and glycosaminoglycan synthesis. MSM provides anti-inflammatory effects by reducing oxidative stress and cytokine production.

Copyright by Neiss Labs Ltd 2025. All rights reserved.